ArticleThe AAPS journal2022

A Fit-for-Purpose Method to Measure Circulating Levels of the mRNA Component of a Liposomal-Formulated Individualized Neoantigen-Specific Therapy for Cancer.

Sebastian Guelman et al.PubMed ↗Publisher ↗

No numbers read from the abstract.